Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients-Reference-Cited by-同舟云学术

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients

Published:2017-07 Issue:7 Volume:5 Page:518-527
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Starling Randall C.,Estep Jerry D.,Horstmanshof Douglas A.,Milano Carmelo A.,Stehlik Josef,Shah Keyur B.,Bruckner Brian A.,Lee Sangjin,Long James W.,Selzman Craig H.,Kasirajan Vigneshwar,Haas Donald C.,Boyle Andrew J.,Chuang Joyce,Farrar David J.,Rogers Joseph G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study;Estep;J Am Coll Cardiol,2015

2. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial;Rogers;Am Heart J,2015

3. Advanced heart failure treated with continuous-flow left ventricular assist device;Slaughter;N Engl J Med,2009

4. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy;Park;Circ Heart Fail,2012

5. Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation;Grady;J Heart Lung Transplant,2014

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024;The Journal of Heart and Lung Transplantation;2024-10

2. Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024);Eurasian heart journal;2024-05-27

3. Therapeutic strategies using a ventricular assistive device for advanced heart failure in Japan;Journal of the Japanese Society of Intensive Care Medicine;2024-05-01

4. Artificial Intelligence Approaches for Predicting the Risks of Durable Mechanical Circulatory Support Therapy and Cardiac Transplantation;Journal of Clinical Medicine;2024-04-03

5. End-stage heart failure: The future of heart transplant and artificial heart;La Presse Médicale;2024-03